Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.

Authors :: Martino M
Pitino A
Gori M
Viens P
Siena S
Tripepi G
Canale FA
Ballestrero A
Zamagni C
Musso M
Zambelli A
Dreger P
Badoglio M
Secondino S
Console G
Chabannon C
Pedrazzoli P
Source :: Bone marrow transplantation [Bone Marrow Transplant] 2022 Feb; Vol. 57 (2), pp. 276-278. Date of Electronic Publication: 2021 Oct 23.
Publication Year :: 2022

Subjects :: Antineoplastic Combined Chemotherapy Protocols therapeutic use
Combined Modality Therapy
Consolidation Chemotherapy
Disease-Free Survival
Female
Humans
Registries
Transplantation, Autologous
Breast Neoplasms drug therapy
Breast Neoplasms pathology
Hematopoietic Stem Cell Transplantation

Full Text Access

Tools